Figure 5 | Scientific Reports

Figure 5

From: Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer

Figure 5

Kaplan-Meier survival analyses based on Shannon index for c-MYC copy number variation after neoadjuvant chemotherapy in subgroups according to chemo-responsiveness. (A) In chemo-resistant group, high Shannon index after neoadjuvant chemotherapy (NAC) shows a significant association with poor disease-free survival. (B) In chemo-sensitive group, it is not associated with disease-free survival of the patient.

Back to article page